SOURCE: InvestSource, Inc.

May 09, 2007 09:22 ET

Physicians Adult Daycare and Health Enhancement Products Hit CEOCorner at

HUNTINGTON BEACH, CA -- (MARKET WIRE) -- May 9, 2007 -- InvestSource, Inc. announced today that Mr. Duane Starkey, President and CEO of Physicians Adult Daycare, Inc. (PINKSHEETS: PHYA), and Mr. Tom Ingolia, CEO of Health Enhancement Products, Inc. (OTCBB: HEPI), were featured in recent installments of CEOCorner, "The Fastest 60 Seconds in the Small-Cap Market." Details of the interviews can be heard at the company profiles for Physicians Adult Daycare and Health Enhancement Products on the InvestSource, Inc. (ISI) website at:, or on the CEOCorner website at:

Physicians Adult Daycare:

Mr. Duane Starkey, President and CEO of Physicians Adult Daycare (PINKSHEETS: PHYA), took the time from his busy schedule to discuss his company's innovative approach to providing conscientious, cost-effective care for the elderly. According to Mr. Starkey, Physicians Adult Daycare is dedicated to developing its business model that provides for the needs of its elder clients while allowing them to retain their independence. The list of services that the PHYA centers provide is extensive, including dietician-supervised meals, activities, use of facilities, and day trips. Mr. Starkey was quite passionate in his desire to point out the growing need for such services, with substantial growth indicators projecting major growth in the market, and the vision of the Company, its employees, and himself to succeed in improving the quality of life for his fellow man. For more information, visit the corporate website at:

Health Enhancement Products, Inc.:

Tom Ingolia, CEO of Health Enhancement Products, Inc. (OTCBB: HEPI), generously agreed to spend some time to discuss the tremendous health benefits of the Company's flagship product, ProAlgaZyme, an all-natural nutraceutical supplement that has been in use for the last ten years. He was especially excited about the extremely positive results in recent clinical trials. For example, in one double-blind study, ProAlgaZyme brought "bad" cholesterol down 32% and raised "good" cholesterol by 41%. Another study is currently being conducted with the results anticipated at the end of summer. In addition, in another separate study, ProAlgaZyme was found to reduce virus levels in AIDS patients up to 32%, prompting the Company to explore the pharmaceutical opportunities of this exciting product. For more information, visit the corporate website at:

About InvestSource, Incorporated (ISI):

ISI is a multimedia relations/public relations firm that specializes in bringing small- and micro-cap public and private companies to the attention of the general public. InvestSource, Inc. believes that there are hosts of undervalued companies that don't get the exposure they deserve, and because of their size, have been overlooked by the larger marketing companies. Many of them have solid business plans, work in potentially highly lucrative niche markets, and have superb growth potential. It is the mission of ISI to empower these companies to reap fully all of the benefits of public exposure. For more information, visit the corporate website at

Safe Harbor Statement:

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of the Company's products, the competitive environment within the industry, the ability of the Company to continue to expand its operations, the level of costs incurred in connection with the Company's expansion efforts, economic conditions in the industry and the financial strength of the Company's customers and suppliers. The Company does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

Contact Information